You are here Home Vaccines Vaccines Infanrix Details for Infanrix (DTPa) vaccine and its components. Listen Print Share Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor GlaxoSmithKline Australia Administration route Intramuscular injection Vaccine group Combination vaccines Description: Registered for primary immunisation in infants aged 2–12 months and as a booster in children aged 15 months to 6 years. DTPa — diphtheria-tetanus-acellular pertussis combination vaccine Each 0.5 mL monodose vial or pre-filled syringe contains: ≥30 IU diphtheria toxoid ≥40 IU tetanus toxoid 25 µg pertussis toxoid 25 µg filamentous haemagglutinin 8 µg pertactin Adsorbed onto 0.5 mg aluminium as aluminium hydroxide. For Product Information and Consumer Medicine Information about Infanrix visit the Therapeutic Goods Administration website - external site. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Diphtheria Pertussis (whooping cough) Tetanus Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
